N. Kim

发表

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

Kyung-Soo Inn, Yeon-Joo Ju, Jong Kil Lee, 2020, Alzheimer's Research & Therapy.

p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice

D. Im, Ju-Hyun Lee, S. Son, 2022, Biomolecules & therapeutics.

3',4'-Dihydroxyflavone mitigates inflammatory responses by inhibiting LPS and TLR4/MD2 interaction.

Kyung-Sook Chung, Hwi-ho Lee, Ji-Sun Shin, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Synthesis of Xanthones via Copper(II)-Catalyzed Dehydrogenative Cyclization and Successive Aromatization in a One-Step Sequence.

Changjin Lim, Jeong-Won Shin, Hyuck-Jae Won, 2022, Organic letters.

Immunotherapy Against Acetylated Tau at K280 Ameliorates Behavioral Impairments and Pathologies of Tau Transgenic Mouse

D. Kim, M. Kim, H. Song, 2020 .

NJK14047 Suppression of the p38 MAPK Ameliorates OVA-Induced Allergic Asthma during Sensitization and Challenge Periods

D. Im, Ju-Hyun Lee, S. Son, 2022, Biomolecules & therapeutics.

Eugenitol ameliorates memory impairments in 5XFAD mice by reducing Aβ plaques and neuroinflammation.

Dong Hyun Kim, W. Cho, M. Moon, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Synthetic 3′,4′-Dihydroxyflavone Exerts Anti-Neuroinflammatory Effects in BV2 Microglia and a Mouse Model

M. Oh, Kyung-Tae Lee, Kyung-Soo Inn, 2018, Biomolecules & therapeutics.

Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease

Yoonji Lee, Kyung-Soo Inn, Na-Rae Lee, 2023, ACS central science.

Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation.

Jong-Ho Kim, Kyung-Soo Inn, M. Seo, 2021, Bioorganic chemistry.

Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitors

H. Choo, H. Lee, Jeong Hyun Jeong, 2022, Journal of enzyme inhibition and medicinal chemistry.

A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced Neuroinflammation in BV2 Microglia and a Mouse Model

M. Oh, H. Jin, J. Bae, 2018, Neurochemical Research.

NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation.

N. Kim, So-Eun Son, Dong-Soon Im, 2024, International immunopharmacology.

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

Kyung-Soo Inn, Yeon-Joo Ju, Jong Kil Lee, 2020, Alzheimer's Research & Therapy.